Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity

International Journal of Pharmaceutics

Volumn 495, Issue 1, 2015, Pages 385-392

  Jannin, Vincent ^a   Chevrier, Stéphanie ^a   Michenaud, Matthieu ^a,b   Dumont, Camille ^a,c   Belotti, Silvia ^a,d   Chavant, Yann ^a   Demarne, Frédéric ^a  

^a GATTEFOSSÉ SAS   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Curcumin; Dispersion; Lipolysis; Nifedipine; Piroxicam; Self emulsifying lipid formulations

Indexed keywords

CURCUMIN; GELUCIRE; LABRASOL; NIFEDIPINE; PIROXICAM; POLYSORBATE 80; SURFACTANT; TRIACYLGLYCEROL LIPASE; ACYLGLYCEROL; EXCIPIENT; LIPID; SOLVENT;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DIGESTION; DISPERSION; DISSOLUTION; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIPOLYSIS; LIPOPHILICITY; MICROSCOPY; PRIORITY JOURNAL; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DELIVERY SYSTEM; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; PROCEDURES; SOLUBILITY;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; CURCUMIN; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GLYCERIDES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPIDS; NIFEDIPINE; PIROXICAM; SOLUBILITY; SOLVENTS; SURFACE-ACTIVE AGENTS;

EID: 84941889664     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.09.009     Document Type: Article

References (34)

1. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
2. P. Archana, N. Sathishkumar, and N. Bharathi In silico docking analysis of curcumin - an inhibitor for obesity Int. J. Pharm. Bio Sci. 1 2010 224 235
3. J.C. Bakala N'Goma, S. Amara, K. Dridi, V. Jannin, and F. Carriere Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systems Ther. Deliv. 3 2012 105 124
4. J.C. Bakala-N'Goma, H.D. Williams, P.J. Sassene, K. Kleberg, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, A. Mullertz, C.W. Pouton, C.J. Porter, and F. Carriere Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase Pharm. Res. 32 2015 1279 1287
5. J. Chamieh, F. Davanier, V. Jannin, F. Demarne, and H. Cottet Size characterization of commercial micelles and microemulsions by Taylor dispersion analysis Int. J. Pharm. 492 2015 46 54
6. J. Cui, B. Yu, Y. Zhao, W. Zhu, H. Li, H. Lou, and G. Zhai Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems Int. J. Pharm. 371 2009 148 155
7. J.F. Cuine, W.N. Charman, C.W. Pouton, G.A. Edwards, and C.J. Porter Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs Pharm. Res. 24 2007 748 757
8. J.F. Cuine, C.L. McEvoy, W.N. Charman, C.W. Pouton, G.A. Edwards, H. Benameur, and C.J. Porter Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs J. Pharm. Sci. 97 2008 995 1012
9. S. Fernandez, S. Chevrier, N. Ritter, B. Mahler, F. Demarne, F. Carriere, and V. Jannin In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14 Pharm. Res. 26 2009 1901 1910
10. S. Fernandez, V. Jannin, S. Chevrier, Y. Chavant, F. Demarne, and F. Carriere In vitro digestion of the self-emulsifying lipid excipient Labrasol((R)) by gastrointestinal lipases and influence of its colloidal structure on lipolysis rate Pharm. Res. 30 2013 3077 3087
11. S. Fernandez, V. Jannin, J.D. Rodier, N. Ritter, B. Mahler, and F. Carriere Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters Biochim. Biophys. Acta 2007 633 640
12. S. Fernandez, J.D. Rodier, N. Ritter, B. Mahler, F. Demarne, F. Carriere, and V. Jannin Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases Biochim. Biophys. Acta 1781 2008 367 375
13. P. Gao, B.D. Rush, W.P. Pfund, T. Huang, J.M. Bauer, W. Morozowich, M.S. Kuo, and M.J. Hageman Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability J. Pharm. Sci. 92 2003 2386 2398
14. R.N. Gursoy, and S. Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 58 2004 173 182
15. N. Heshmati, X. Cheng, E. Dapat, P. Sassene, G. Eisenbrand, G. Fricker, and A. Mullertz In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems J. Pharm. Pharmacol. 66 2014 1567 1575
16. V. Jannin, J. Musakhanian, and D. Marchaud Approaches for the development of solid and semi-solid lipid-based formulations Adv. Drug Deliv. Rev. 60 2008 734 746
17. V. Jannin, J.D. Rodier, and J. Musakhanian Polyoxylglycerides and glycerides: effects of manufacturing parameters on API stability, excipient functionality and processing Int. J. Pharm. 466 2014 109 121
18. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25
19. P.B. Memvanga, R. Coco, and V. Preat An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with beta-arteether J. Control. Release 172 2013 904 913
20. Y.B. Pawar, H. Purohit, G.R. Valicherla, B. Munjal, S.V. Lale, S.B. Patel, and A.K. Bansal Novel lipid based oral formulation of curcumin: development and optimization by design of experiments approach Int. J. Pharm. 436 2012 617 623
21. W.C. Pouton Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 29 2006 278 287
22. C.W. Pouton, and C.J.H. Porter Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies Adv. Drug Deliv. Rev. 60 2008 625 637
23. H.J. Roth, and B. Miller Zur Kenntnis der Farbreaktion zwischen Borsäure und Curcumin. I. Borinsäure-Curcumin-Komplexe Archiv der Parmazie und Berichte der Deutschen Parmazeutischen Gesellschaft 297 1964 617 623
24. P. Sassene, K. Kleberg, H.D. Williams, J.C. Bakala-N'Goma, F. Carriere, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, C.J. Porter, C.W. Pouton, and A. Mullertz Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels AAPS J. 16 2014 1344 1357
25. S. Setthacheewakul, S. Mahattanadul, N. Phadoongsombut, W. Pichayakorn, and R. Wiwattanapatapee Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats Eur. J. Pharm. Biopharm. 76 2010 475 485
26. A. Tan, S. Rao, and C.A. Prestidge Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance Pharm. Res. 30 2013 2993 3017
27. N. Thomas, K. Richter, T.B. Pedersen, R. Holm, A. Mullertz, and T. Rades In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate AAPS J. 16 2014 539 549
28. A. Tsuji, E. Nakashima, S. Hamano, and T. Yamana Physicochemical properties of amphoteric β-lactam antibiotics I: stability, solubility, and dissolution behavior of amino penicillins as a function of pH J. Pharm. Sci. 67 1978 1059 1066
29. H.D. Williams, M.U. Anby, P. Sassene, K. Kleberg, J.C. Bakala-N'Goma, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, F. Carriere, A. Mullertz, C.W. Pouton, and C.J. Porter Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion Mol. Pharm. 9 2012 3286 3300
30. H.D. Williams, P. Sassene, K. Kleberg, J.C. Bakala-N'Goma, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, F. Carriere, A. Mullertz, C.J. Porter, and C.W. Pouton Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations J. Pharm. Sci. 101 2012 3360 3380
31. H.D. Williams, P. Sassene, K. Kleberg, M. Calderone, A. Igonin, E. Jule, J. Vertommen, R. Blundell, H. Benameur, A. Mullertz, C.J. Porter, and C.W. Pouton Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system J. Pharm. Sci. 103 2014 2441 2455
32. H.D. Williams, P. Sassene, K. Kleberg, M. Calderone, A. Igonin, E. Jule, J. Vertommen, R. Blundell, H. Benameur, A. Mullertz, C.W. Pouton, and C.J. Porter Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations Pharm. Res. 30 2013 3059 3076
33. C.Y. Wu, and L.Z. Benet Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system Pharm. Res. 22 2005 11 23
34. X. Wu, J. Xu, X. Huang, and C. Wen Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability Drug Dev. Ind. Pharm. 37 2011 15 23